-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Tarsus Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2024.
- Tarsus Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $1.31M, a 48.7% decline year-over-year.
- Tarsus Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $5.02M, a 31% decline year-over-year.
- Tarsus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2024 was $5.02M, a 31% decline from 2023.
- Tarsus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $7.27M, a 1077% increase from 2022.
- Tarsus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $617K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)